The Polio Vaccine Market is dominated by two types of vaccines: inactivated polio vaccine (IPV) and oral polio vaccine (OPV). IPV is an injectable vaccine that contains inactivated poliovirus, while OPV is an oral vaccine that contains weakened live poliovirus. Both vaccines are effective in preventing polio, but they have different advantages and disadvantages.
OPV is the vaccine that has been used in most of the polio eradication campaigns to date. This is because it is cheaper and easier to administer than IPV. OPV also has the advantage of providing herd immunity, which means that even unvaccinated individuals can be protected from the disease if a high enough percentage of the population is vaccinated. However, OPV can sometimes cause the disease it is designed to prevent, and it can also lead to the development of vaccine-derived poliovirus in rare cases.
IPV, on the other hand, is more expensive and requires skilled healthcare workers to administer. However, Polio Vaccine Market has the advantage of not causing the disease it is designed to prevent, and it cannot lead to the development of vaccine-derived poliovirus. IPV is also more effective than OPV in preventing the spread of the disease in areas where sanitation is poor.
![The Ultimate Guide to Creating an Uber for X App [2022]](https://www.businessinmyarea.com/upload/media/posts/2022-08/18/the-ultimate-guide-to-creating-an-uber-for-x-app-2022_1660813826-s.jpg)
